geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children


, : The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clinical Infectious Diseases 40(10): 1511-1518

Introduction. Pneumococcal conjugate vaccine (PnCV) may be used as a probe to define the burden of pneumococcal disease and better characterize the clinical presentation of pneumococcal pneumonia.Methods. This study used a 9-valent PnCV to define different end points of vaccine efficacy and the preventable burden of pneumococcal pneumonia in 39,836 children who were randomized in a double-blind, placebo-controlled trial in South Africa.Results. Whereas the point-estimate of vaccine efficacy was greatest when measured against the outcome of vaccine-serotype specific pneumococcal bacteremic pneumonia (61%; P = .01), the sensitivity of blood culture to measure the burden of pneumococcal pneumonia prevented by vaccination was only 2.6% in human immunodeficiency virus (HIV)-uninfected children and 18.8% in HIV-infected children. Only 37.8% of cases of pneumococcal pneumonia prevented by PnCV were detected by means of chest radiographs showing alveolar consolidation. A clinical diagnosis of pneumonia provided the best estimate of the burden of pneumococcal pneumonia prevented through vaccination in HIV-uninfected children (267 cases prevented per 100,000 child-years) and HIV-infected children (2573 cases prevented per 100,000 child-years).Conclusion. Although outcome measures with high specificity, such as bacteremic pneumococcal pneumonia, provide a better estimate as to vaccine efficacy, the burden of disease prevented by vaccination is best evaluated using outcome measures with high sensitivity, such as a clinical diagnosis of pneumonia.

US$19.90

PMID: 15844075

DOI: 10.1086/429828


Other references

Borawski, J.; Pawlak, K.; Myśliwiec, Mł., 2002: Inflammatory markers and platelet aggregation tests as predictors of hemoglobin and endogenous erythropoietin levels in hemodialysis patients. Background/Aims: Chronic inflammation is a common cause of severe anemia and hyporesponsiveness to recombinant erythropoietin (EPO) therapy in maintenance hemodialysis (HD) patients. We compared various acute-phase markers and ex vivo platelet agg...

Komoda K., 1990: Immunopathological study of glomerulonephritis in chronic serum sickness in rats. The kinetics of immune complexes, the immune deposits and glomerular changes were studied in nephrotic rats. Chronic serum sickness was induced in rats and examined for 80 weeks, injections of bovine serum albumin (BSA) having been stopped at the...

Gabriel, R.; Akopian, A.; Witkovsky, P., 1998: Co-localization of ryanodine and inositol trisphosphate receptors in retinal ganglion cells. IOVS 39(4): S986, March 15

Auringer, S.T.; Scharling, E.S.; Sumner, T.E., 1996: CT of the pediatric gastrointestinal tract. Despite the fact that children are not small adults, some children will invariably be evaluated with adult imaging protocols. As CT gains popularity in the evaluation of the adult gastrointestinal (GI) tract, there will undoubtedly be some spillov...

Seaborn, T.; Masmoudi-Kouli, O.; Fournier, A.; Vaudry, H.; Vaudry, D., 2011: Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis. Apoptosis is a regulated process leading to cell death, which is implicated both in normal development and in various pathologies including heart failure, stroke and neurodegenerative diseases. Caspase-3, a key enzyme of the apoptotic pathway, is...

Moore, R.; Barrera, H.; Troutt, A.B.; Von Hoff, D.; Weitman, S., 1999: Interaction of TRAIL and standard cytotoxic agents against a panel of human tumor cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 40: 9, March

Mcneely, Jeffery A., 1997: Global diversity forum. Environmental Conservation 24(1): 87-88

Lu, Y-Hsueh.; Dallner, O.Stefan.; Birsoy, K.; Fayzikhodjaeva, G.; Friedman, J.M., 2015: Nuclear Factor-Y is an adipogenic factor that regulates leptin gene expression. Leptin gene expression is highly correlated with cellular lipid content in adipocytes but the transcriptional mechanisms controlling leptin expression in vivo are poorly understood. In this report, we set out to identify cis- and trans-regulatory...

Becker C.G.; Hardy A.M., 1973: Contractile protein in endothelial cells of cerebral arteries and arterioles comparison of normotensive and malignant hypertensive states. Circulation Supplement 48(4): IV-44

Crounse, R.G.; Maxwell, J.D.; Blank, H., 1962: Inhibition of growth of hair by mimosine. Nature 194: 694-695